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Abstract 
Background: Disparities in invasive cervical cancer (ICC) incidence exist globally, particularly in HIV positive women 
who are at elevated risk compared to HIV negative women. We aimed to determine the spatial, temporal, and spati‑
otemporal incidence of ICC and the potential risk factors among HIV positive women in South Africa.
Methods: We included ICC cases in women diagnosed with HIV from the South African HIV cancer match study dur‑
ing 2004–2014. We used the Thembisa model, a mathematical model of the South African HIV epidemic to estimate 
women diagnosed with HIV per municipality, age group and calendar year. We fitted Bayesian hierarchical models, 
using a reparameterization of the Besag‑York‑Mollié to capture spatial autocorrelation, to estimate the spatiotemporal 
distribution of ICC incidence among women diagnosed with HIV. We also examined the association of deprivation, 
access to health (using the number of health facilities per municipality) and urbanicity with ICC incidence. We cor‑
rected our estimates to account for ICC case underascertainment, missing data and data errors.
Results: We included 17,821 ICC cases and demonstrated a decreasing trend in ICC incidence, from 306 to 312 in 
2004 and from 160 to 191 in 2014 per 100,000 person‑years across all municipalities and corrections. The spatial rela‑
tive rate (RR) ranged from 0.27 to 4.43 in the model without any covariates. In the model adjusting for covariates, the 
most affluent municipalities had a RR of 3.18 (95% Credible Interval 1.82, 5.57) compared to the least affluent ones, 
and municipalities with better access to health care had a RR of 1.52 (1.03, 2.27) compared to municipalities with 
worse access to health.
Conclusions: The results show an increased incidence of cervical cancer in affluent municipalities and in those with 
more health facilities. This is likely driven by better access to health care in more affluent areas. More efforts should be 
made to ensure equitable access to health services, including mitigating physical barriers, such as transportation to 
health centres and strengthening of screening programmes.
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mmons. org/ licen ses/ by/4. 0/. The Creative Commons Public Domain Dedication waiver (http:// creat iveco mmons. org/ publi cdoma in/ 
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Background
HIV positive women have an up to five times higher risk 
of developing invasive cervical cancer (ICC) compared 
with HIV negative women [1]. Persistent infection with 
high-risk variants of the human papillomavirus (HPV) is 
a necessary cause for ICC [2]. In 2020, Southern Africa 
and Eastern Africa had the highest burden of cervical 
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cancer worldwide with an incidence rate of over 40 and 
36 cases per 100,000 population per year respectively [3, 
4].
The two regions also have a high burden of HIV: 54% 
of people living with HIV worldwide live in Southern 
and Eastern Africa [5]. A study looking at the global ICC 
estimated determine that in Southern Africa, 53% of ICC 
cases were attributable to HIV [6].
In 2019, the World Health Organization called for the 
elimination of cervical cancer as a public health threat 
[7–9]. ICC can be prevented through HPV vaccina-
tion and early detection and treatment of pre-cancerous 
cervical lesions. When implemented effectively, these 
methods should result in decreased disease burden. 
However, globally there are disparities in ICC burden, 
even amongst HIV positive women. A global study dem-
onstrated that HIV positive women in South Africa had 
a substantially higher incidence of ICC compared to the 
rest of the world, even after the introduction of antiret-
roviral therapy (ART) [10]. Poor access to screening, long 
waiting times for treatment of pre-cancerous cervical 
lesions as well as the socioeconomic inequities that exist 
in the country contribute to the high burden of ICC in 
South Africa [11, 12].
Spatiotemporal analysis of ICC incidence among HIV 
positive women can be used for disease surveillance over 
time and space, and to identify potential causes of the 
unequal distribution of ICC incidence. In this nationwide 
study in South Africa during 2004–2014, we examine the 
spatial, temporal and spatiotemporal incidence of ICC 
among women diagnosed with HIV. We perform three 
different corrections on the incidence rates to account 
for under-ascertainment, missing data and data errors. 
We assess whether urbanicity, deprivation and number 
of health facilities in a municipality (proxy for access to 




In 2016, South Africa was divided into 9 provinces and 
213 municipalities (Additional file  1: Figures  S5-6). 
The area of the municipalities varies from 828.1   km2 to 
44,231.3   km2. The population in 2016 was 55.7 million, 
varying from 8895 to 4,949,347 across the municipalities. 
The ethnic breakdown amongst South African women 
was 80.6% Black, 8.1% White, 8.9% Mixed race and 2.4% 
Asian [13].
Study population
We retrieved data on women diagnosed with ICC with 
an HIV positive status in South Africa for the period 
2004–2014 from the South African HIV cancer match 
(SAM) study [14]. The SAM study aims to estimate can-
cer incidence in people living with HIV. It uses probabil-
istic record linkage methods to build a national cohort of 
people living with HIV from HIV-related laboratory tests 
stored at the National Health Laboratory Service (NHLS) 
and ICC cancer cases recorded in the National Cancer 
Registry (NCR) [14]. The HIV data includes laboratory 
HIV diagnostic tests like enzyme-linked immunosorbent 
assay (ELISA), qualitative and quantitative polymerase 
chain reaction (PCR) as well as the Western Blot. In addi-
tion, the HIV data includes HIV laboratory monitoring 
tests such as CD4 cell counts and HIV RNA viral loads 
[14]. The NCR is a nationwide, pathology-based cancer 
registry in South Africa with compulsory cancer report-
ing of cancer cases by both private and public laborato-
ries since 2011 [15]. The NHLS is the largest diagnostic 
pathology service in South Africa, providing health ser-
vices to about 80% of the population of South Africa 
(almost entirely users of public health facilities) [15].
We included ICC cases diagnosed within 2  years 
prior to a first HIV laboratory test or later, assuming 
that women would have been HIV-positive on average 
for at least 2  years prior to the test. The NHLS collects 
addresses of facilities where HIV tests are performed. We 
geocoded these addresses using Google Maps and linked 
them with corresponding municipalities. We assumed 
that the municipality of residence is the municipality 
where the women received the HIV-related test result.
We estimated the number of person-years of women 
diagnosed with HIV in each municipality using the 
Thembisa model (version 4.3; https:// www. themb isa. org/ 
downl oads) [16]. Thembisa is a mathematical model of 
the South African HIV epidemic, which provides provin-
cial counts of cases diagnosed with HIV, stratified by age 
and sex. Since the Thembisa model does not provide esti-
mates by municipality, we applied weights (by age, year 
and municipality) using NHLS data on women diagnosed 
with HIV to obtain municipal HIV estimates (see Addi-
tional file 1: Text S1.1 for the weight calculation and Fig-
ure S1 for the exclusion criteria of the NHLS).
Outcome
The NCR classifies cancer diagnoses according to the 
International Classification of Diseases for Oncology 
third edition (ICD-O-3), excluding pre-cancerous lesions 
[17]. We included cervical cancers coded C53.0, C53.1, 
C53.8 and C53.9.
Co‑variates
We examined socioeconomic differentials across space 
using a multiple deprivation rank as determined in 
2011 [18]. The most deprived ward is given a rank of 1. 
To adjust for differences in access to health care, we 
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considered the urbanicity of the municipalities (urban–
rural) as retrieved from the National Department of 
Health data dictionary which was last updated in 2019 
(Additional file  1: Figure S2), and the number of health 
facilities per municipality 2004–2014 from NHLS, as a 
proxy for access to health services (Additional file 1: Fig-
ure S3) [19]. The health facility information in the NHLS 
dataset refers to primary and secondary care clinics and 
hospitals as well as regional and national hospitals from 
which the HIV test was requested. The spatial and spa-
tiotemporal analysis was based on the addresses of these 
health facilities.
Statistical methods
We used Bayesian hierarchical models to investigate the 
spatial and spatiotemporal distribution of ICC incidence 
among women diagnosed with HIV in South Africa. We 
first performed model selection without incorporating 
any covariates. Briefly, we used a re-parameterisation of 
the Besag-York-Mollié model to model the spatial auto-
correlation [20–22]. This reparameterization includes 
a standard deviation hyperparameter that controls the 
variation of the field and a mixing hyperparameter indi-
cating the proportion of the field that is dominated by 
strong spatial variation (ICAR prior [20]) as opposed to 
overdispersion. Random walk (RW) processes of order 
one were used to estimate the temporal random effect 
(on yearly resolution) and the random effects for the dif-
ferent age groups (15–19, 20–24, …, 75–79, > 80  years). 
We fitted a series of models taking all possible combi-
nations of the aforementioned random effects and also 
considered a type I interaction (interaction between an 
unstructured temporal and spatial random effects) [23]. 
We used penalized complexity priors for all the hyperpa-
rametes (Additional file 1: Text S1.2) [21, 24]. To examine 
model performance and select the best performing model 
we derived the deviance information criterion (DIC), the 
Watanabe–Akaike information criterion (WAIC), and 
the mean logarithmic score (CPO) [25]. In a second step, 
we used the model that fitted best and adjusted for the 
selected covariates. The model of best fit was determined 
as the one that minimizes the DIC, WAIC and CPO. We 
categorised the deprivation rank and number of health 
facilities per municipality in deciles to allow flexible fits. 
Additional file 1: Text S1.2 provides further information 
about the model specification.
Incidence corrections
We report four different estimates of the ICC incidence 
among women diagnosed with HIV. The first incidence 
estimates (‘no correction’) are from the best fitting model 
(without covariates).
The first correction (‘correction I’) accounts for the 
potential diagnosis of HIV in the private sector. NCR 
includes cases diagnosed in the private and public sec-
tor. The correction assumes that if an NCR case is diag-
nosed in the private sector, then the women are likely 
to have received the HIV diagnosis and care in the 
private sector, too. Out of the total 57,161 ICC cases 
diagnosed during 2004–2014 in South Africa, 32,564 
were not linked with an HIV case. However, out of the 
32,564, only 5,077 (16%) were diagnosed in the private 
sector. We assumed that (57,161–32,564)/57,161 = 43% 
of these cases are HIV related. Thus, for correction I, 
we oversampled 5077*0.43 = 2,183 cases (on average 
1,596 remained after the inclusion criteria) from the 
linked ICC cases that were treated in the private sector. 
To account for the sampling uncertainty, we fitted the 
model 100 times and averaged over the samples using 
Bayesian model averaging [26].
For the second correction (‘correction II’), we used 
information about Kaposi sarcoma (KS). KS is a rare 
cancer in HIV-negative people but the most common 
cancer in people living with HIV [27]. In the SAM 
study, 70% of the 23,046 KS cases could be linked 
probabilistically to an HIV test. Out of the KS cases 
not linked, 1890 (8.2%) were diagnosed in the private 
sector. If we assume that all KS cases diagnosed from 
2004 to 2014 occurred among people living with HIV, 
then the remaining 30%–8.2% = 21.8% missing HIV 
tests may be due to under-ascertainment of HIV, data 
errors or inaccuracies preventing linkage. To correct 
for the above, we calculated the proportion of unlinked 
KS cases by municipality excluding those treated in the 
private sector (because correction I accounts for that), 
and corrected the recorded numbers of ICC cases using 
the KS linked proportions (Additional file 1: Text S1.3). 
The third correction combines, by means of summing, 
the additional cases from corrections I and II (referred 
to as ‘full correction’).
We report median posterior and 95% credibility 
intervals (CrIs) for the temporal ICC incidence rate and 
performed age standardisation based on the world pop-
ulation weights [28]. We report median posterior of the 
exponential of the spatial random effects (spatial rela-
tive rates or spatial RRs; relative to the national aver-
age incidence rate over time), RRs for the effect of the 
selected covariates (relative to the baseline) and pos-
terior probabilities (that the RRs is higher than 1). We 
used integrated nested Laplace approximation (INLA) 
for Bayesian inference [29]. The data and the code used 
for the analysis are online available https:// github. com/ 
gkons tanti noudis/ Cervi xHIVR SA.
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Results
Study setting and population
We identified 57,161 ICC cases diagnosed from 
2004 to 2014 in South Africa in the SAM study. We 
excluded 32,393 cases not linked with an HIV record 
and ≥ 15 years old, 1607 with missing or imprecise geoc-
odes, 3666 with a ICC diagnosis 2 years or more before 
their first HIV related laboratory test and 1674 cases 
residing in KwaZulu-Natal leaving us with 17,821 (~ 32%) 
cases for the main analysis (Fig.  1). We excluded the 
KwaZulu-Natal province because it started contributing 
data to NHLS only in 2010. With correction I, the total 
number of cases varied from 19,380 to 19,466. It was 
21,446 for correction II and varied from 23,005 to 23,091 
for the full correction. The total person-years (PY) at risk 
among women diagnosed with HIV during 2004–2014 
were 24,059,679.
Model selection
Based on the DIC, WAIC and CPO the model with the 
best fit was the one with random effects for age, time, 
space and a space–time interaction (Additional file  1: 
Table S1).
Co‑variates
The spatial distribution of the deciles of deprivation 
rank and number of health facilities is shown in Fig.  2. 
The spatial distribution of urbanicity is shown in the 
Additional file  1: Figure S2. There were 23 urban and 
190 rural municipalities in South Africa in 2016. Over-
all, we observe substantial spatial variation for all three 
covariates.
Overall incidence
The median overall ICC incidence during 2004–2014 
from the best fitting model was 294 (95% CrI: 174, 498) 
for no correction, 297 (95% CrI: 163, 573) for correc-
tion I, 310 (95% CrI: 170, 494) for correction II and 312 
(95% CrI: 171, 510) for the full correction, per 100,000 
PY, among women diagnosed with HIV (Additional file 1: 
Table S2).
Temporal trends
Figure 3 shows that the annual median age-standardized 
ICC incidence rate per 100,000 PY of women diagnosed 
with HIV in South Africa decreased during 2004–2014. Fig. 1 Flow of selection of eligible cervical cancer cases
Fig. 2 Maps of the deciles of the deprivation rank and number of health facilities per municipality
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In 2004, the incidence rate varied from 306 (95% CrI: 169, 
555) for no correction, to 306 (95% CrI: 163, 573) for cor-
rection I, and to 310 (95% CrI: 164, 589) for correction II 
and 312 (95% CrI: 160, 609) for the full correction, per 
100,000 PY (Table  S2 in Additional file  1:). In contrast, 
in 2014 the incidence rate varied from 160 (95% CrI: 96, 
265) for no correction, to 179 (95% CrI: 106, 303) for 
correction I, to 172 (95% CrI: 103, 290) for correction II 
and to 191 (95% CrI: 113, 326) for the full correction, per 
100,000 PY (in Additional file 1: Table S2).
Spatial patterns
Figure 4 shows the median posterior spatial RR and pos-
terior probability of ICC across women diagnosed with 
HIV in the no correction model without covariates (top 
panels) and the no correction model adjusted for the 
selected covariates (bottom panels). For the model with-
out covariates, the spatial RR ranged from 0.27 (95% CrI: 
0.16, 0.42) to 4.43 (95% CrI: 3.71, 5.28). There was attenu-
ation of associations when adjusting for covariates with 
the RR varying from 0.35 (95% CrI: 0.18, 0.64) to 4.10 
(95% CrI: 2.90, 5.78). Nevertheless, the spatial variation 
remained strong after having adjusted for the selected 
covariates, with the mixing hyperparameter being 0.77 
(0.45, 0.95), Additional file 1: Table S3. RR and posterior 
probabilities were larger in the province of the North-
ern Cape (north-western region of the map) and the 
Limpopo, Gauteng and Mpumalanga provinces (north-
eastern part of the map) (Additional file 1: Figure S3). The 
results across the incidence corrections are similar, Addi-
tional file 1: Figure S7.
Spatiotemporal patterns
The spatial differences have not attenuated over the 
years, and the patterns do not seem to be consistent in 
both ‘no correction’ models, with and without covariates 
(Fig. 5 and Additional file 1: Figure S8). The results across 
the incidence corrections are similar, Additional file  1: 
Figure S9–15.
Influence of covariates
We assessed the influence of covariates in the no correc-
tion model (Table  1). The RR comparing the least with 
the most deprived municipalities was 3.56 (95% CrI: 
2.16–5.89) in the univariable model, and 3.18 (95% CrI: 
1.82–5.57) in the multivariable model. The RR in munici-
palities with the highest number of health facilities was 
1.83 (95% CrI: 1.27–2.64) in the univariable model, and 
1.52 (95% CrI: 1.03–2.27) in the multivariate model, com-
pared to municipalities with the lowest number of health 
facilities. There was little evidence of a difference in ICC 
incidence across urban and rural municipalities, both in 
the univariable (1.19, 95% CrI 0.94–1.50) and multivari-
able model (0.85, 95% CrI 0.65–1.12).
Fig. 3 Yearly age‑standardised incidence rate per 100,000 person years for women living with HIV in South Africa
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Discussion
Main findings
In this study, we determined the spatial, temporal and 
spatiotemporal variation of ICC incidence in women 
diagnosed with HIV in South Africa, and assessed 
whether urbanicity deprivation and number of health 
facilities explained any geographical or spatiotemporal 
patterns. We observed an overall decreasing trend in 
ICC incidence in women diagnosed with HIV in South 
Africa during 2004–2014. We found a higher relative 
incidence in the Northern Cape and in the Limpopo, 
Gauteng and Mpumalanga provinces. Regarding the 
spatiotemporal patterns, the spatial differences did not 
decrease over time. Also, HIV positive women residing 
in the least deprived municipalities or in municipalities 
with larger numbers of health facilities were more likely 
to get diagnosed with ICC.
Discussion in the context of previous studies
The incidence observed across all corrections is consist-
ent with other studies on ICC incidence in women living 
with HIV in South Africa. Two hospital-based cohort 
studies determined crude incidence rates that ranged 
from 447 to 506 ICC cases/100,000 person-years [10, 30]. 
These results reflect the high ICC burden in HIV positive 
women in South Africa compared to the overall crude 
incidence rate of ICC in the general South African popu-
lation. The latter experienced an incidence of 22.68 ICC 
cases/100,000 of the population as of 2016 [31]. Other 
HIV and cancer registry linkage studies in Africa have 
shown variable crude incidence rates in women living 
with HIV. In Nigeria, investigators observed an incidence 
of 7.8/ 100,000 person-years [32] whilst in Uganda, the 
incidence reported was 70/ 100 000 person-years, with 
the incidence being highest in the 35–44 age group at 
Fig. 4 Median posterior of spatial relative risk (exponential of the spatial random effect) and posterior probability. The posterior probability that 
relative risk is larger than 1 of cervical cancer compared to the national average during 2004–2014 for the model without any correction and 
covariates (top panels) and the fully adjusted model without any correction (bottom panels)
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200/100,000 person-years [33]. These differences in ICC 
incidence might potentially reflect differences in access 
to ICC screening and diagnosis in the different countries.
Although CC incidence in women diagnosed with 
HIV is still high compared to the general population, 
we observed a decreasing trend in ICC incidence after 
an initial increase between 2004 and 2006, similar to the 
decline that was observed in high income countries after 
the introduction of ART [34, 35]. However, in other Afri-
can settings, the ICC incidence trends either remained 
unchanged or increased even after the introduction of 
ART [33, 36]. The decline in incidence in our study might 
reflect the HIV testing patterns in South Africa across the 
study period. Initially, fewer people were tested for HIV 
[37] and those tested had an increased burden of disease 
and lower CD4 cell counts [38]. Increased ICC incidence 
has been associated with very low CD4 cell counts com-
pared to higher CD4 cell counts. With time, as HIV test-
ing expanded, more women had access to timely HIV 
diagnosis and treatment before advanced disease, thus 
reducing the likelihood of ICC. The timely access might 
have resulted in the subsequent decline in ICC incidence 
from 2006 amongst women diagnosed with HIV. ART 
reduces the prevalence of high-risk HPV infections and 
Fig. 5 Posterior probability that the spatiotemporal relative risk (relative to the national average over time and space) of cervical cancers among 
women living with HIV in South Africa is higher than 1. This figure is based on the model without any covariates and corrections
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cervical pre-cancerous lesions. Still, the effect is reduced 
in individuals initiating ART at an advanced HIV stage 
and in women with advanced pre-cancerous lesions 
[39–41]. The expansion of the national ART programme, 
which started in 2004, ensured that more people had 
access to HIV treatment and subsequently improved CD4 
cell counts. This expansion could also explain the subse-
quent decline in incidence from 2006 to 2014 as women 
had a lower burden of disease and better access to ART. 
However, in some studies this has not been supported. 
In Botswana, no significant change in ICC incidence 
was observed after ART expansion [36]. Spatial analyses 
have been used in ICC studies to determine disparities 
in incidence and mortality as well as the factors associ-
ated with the unequal distribution of ICC burden [30, 
42–45]. However, all these studies focused on the gen-
eral population regardless of HIV status. Previous stud-
ies examining the spatial trends in the USA, Thailand and 
Cuba have reported variations in ICC incidence driven by 
a variety of factors [42, 46, 47]. In Thailand, Zhao et  al. 
observed differences in ICC incidence in districts in the 
Songhkla province driven by sexual behaviour and migra-
tion patterns [47]. A similar study in Cuba showed that 
differences in screening programme coverage did not 
account for the spatial differences in ICC incidence, 
which were better explained by differences in lifestyle 
and socioeconomic status [43]. In the USA, the dispari-
ties were attributed to ethnicity, socioeconomic status 
and screening coverage [42]. Low socioeconomic status 
of areas and low screening rates were associated with an 
increased ICC incidence. Another spatiotemporal study 
in Texas, USA demonstrated that poor education, African 
and Hispanic ethnicities and low socioeconomic status 
was associated with a high ICC incidence [48]. In South 
Africa, Black women have a higher incidence of ICC 
compared to other races. The incidence of ICC amongst 
black women in 2017 was 28.25 per 100 000 women com-
pared to 8.29, 13.66 and 15.24 in Asian, Mixed race and 
White women respectively [31]. This is largely attributed 
to differences in HIV prevalence as well as unequal access 
to health care services. However, in our study data on 
ethnicity was not available.
In our study, more affluent areas had a higher inci-
dence of ICC. People living in the least deprived 
municipalities were about three times more likely to be 
diagnosed with ICC. This points towards disparities in 
Table 1 Median posterior relative rate and 95% credibility intervals of the effect of the covariates
CrI, Credibility intervals; Pr(RR > 1), Posterior probability that the relative rate is larger than 1. The models were adjusted for urbanicity, deprivation rank and number of 
health facilities as a proxy for access to health
Univariable models Mutlivariable model
Co‑variates Median 95% CrI Pr(RR > 1) Median 95% CrI Pr(RR > 1)
Urbanicity Rural 1.00 – 1.00 1.00 – 1.00
Urban 1.19 (0.94, 1.50) 0.92 0.85 (0.65, 1.12) 0.12
Deprivation rank 1st Decile 1.00 – 1.00 1.00 – 1.00
2nd Decile 1.81 (1.16, 2.82) 1.00 1.77 (1.13, 2.78) 0.99
3rd Decile 1.84 (1.19, 2.86) 1.00 1.68 (1.07, 2.66) 0.99
4th Decile 2.14 (1.35, 3.40) 1.00 1.97 (1.23, 3.16) 1.00
5th Decile 1.76 (1.09, 2.83) 0.99 1.83 (1.10, 3.04) 0.99
6th Decile 2.22 (1.41, 3.49) 1.00 1.97 (1.23, 3.17) 1.00
7th Decile 2.40 (1.50, 3.85) 1.00 2.33 (1.43, 3.79) 1.00
8th Decile 2.82 (1.78, 4.50) 1.00 2.69 (1.66, 4.35) 1.00
9th Decile 3.21 (1.98, 5.21) 1.00 2.88 (1.75, 4.74) 1.00
10th Decile 3.56 (2.16, 5.89) 1.00 3.18 (1.82, 5.57) 1.00
Number of health facilities 1st Decile 1.00 – 1.00 1.00 – 1.00
2nd Decile 1.16 (0.68, 1.98) 0.71 1.14 (0.67, 1.92) 0.69
3rd Decile 0.97 (0.66, 1.42) 0.43 0.90 (0.62, 1.31) 0.29
4th Decile 1.14 (0.77, 1.68) 0.74 1.04 (0.71, 1.55) 0.59
5th Decile 1.24 (0.86, 1.81) 0.87 1.06 (0.73, 1.54) 0.61
6th Decile 1.17 (0.79, 1.74) 0.78 1.07 (0.72, 1.60) 0.64
7th Decile 1.15 (0.80, 1.67) 0.77 1.05 (0.72, 1.56) 0.61
8th Decile 1.31 (0.91, 1.89) 0.93 1.18 (0.81, 1.71) 0.81
9th Decile 1.35 (0.93, 1.97) 0.95 1.24 (0.85, 1.83) 0.87
10th Decile 1.83 (1.27, 2.64) 1.00 1.52 (1.03, 2.27) 0.98
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ICC, driven by unequal access to services due to socio-
economic circumstances. In Uganda, a spatial analysis 
of ICC in women, regardless of HIV status, showed 
that areas of low socioeconomic status had decreased 
access to care, including ICC screening [44]. This can 
lead to a spurious negative association between ICC 
incidence and socioeconomic status, as areas of low 
socioeconomic status would appear to have a lower 
burden of disease when the ICC cases are not being 
diagnosed. Some districts in South Africa have pro-
nounced shortages of health care staff, with multiple 
vacant posts and ill-equipped facilities [49], which 
affects access to care. In addition, utilisation of public 
health sector facilities in South Africa has been shown 
to be higher among people from least deprived areas, 
with individuals from deprived areas having limited 
access to public health sector services [50].
We observed a relationship between the number of 
facilities per municipality and ICC incidence in women 
diagnosed with HIV: the greater the number of health 
facilities, the higher the ICC incidence. In our study, 
we used the number of health facilities per municipal-
ity as a proxy for differences in access to health care 
services. This points to the effect of inequalities in 
access to care on ICC incidence. In the United States, 
in urban areas, a larger distance to the health facil-
ity was a barrier to accessing cervical cancer care and 
treatment [51]. However, the same was not observed 
in rural areas, where long distances were associated 
with better access, with the suggested reason being 
the familiarity and tolerance to long-distance travel for 
health services in rural areas [51]. A qualitative study 
in Botswana determined thematic issues that affected 
access to ICC treatment and care. Among those were 
contextual issues like distance from facility, other com-
mitments and transportation issues as well as health 
system issues such as long waiting times for appoint-
ments with health care workers and for test results 
[52]. In South Africa, it is estimated that for every 
additional health care professional per year, the like-
lihood of cervical cancer screening improved by 1% 
[53].
Deprivation, access to health and urbanicity did 
not explain all of the observed spatial variation. The 
remaining spatial trends can point towards geographi-
cal health inequalities, potentially generated by dif-
ferent screening programmes and municipality level 
health policies. Differences in HPV prevalence might 
also influence the ICC incidence patterns. There was 
no readily available nationwide screening coverage 
data or ethnicity data at the municipality level for 
women diagnosed with HIV at the time of analysis.
Strengths and limitations
To our knowledge, our study is the first nationwide 
study to describe the temporal, spatial and spatiotempo-
ral variation in ICC incidence by municipality amongst 
women diagnosed with HIV in South Africa. Given 
that our data sources cover the majority of the South 
African population, and given the incidence adjust-
ments we made, our incidence estimates are expected 
to cover the majority of women diagnosed with HIV in 
South Africa. The correction factors reduced the selec-
tion bias introduced through our data sources and the 
record linkage process. However, our study also has 
several limitations. In our study, the population under 
observation was specific to a sub-population of women 
who knew their HIV status and thus had contact with 
health care facilities. This contact increases the prob-
ability of being referred for ICC screening and treat-
ment when compared to women who are unaware 
of their HIV status. As a result, the results cannot be 
generalised to women who have not been diagnosed 
with HIV. According to a survey by the Human Sci-
ence Research Council, 47.5% of women aged 15 years 
and older were unaware of their HIV positive status in 
2017 [54]. Although we introduced several incidence 
corrections, women without health care access are 
missing from our study. The ecological nature of our 
analysis did not allow us to adjust for CD4 counts that 
might influence ICC incidence. We could not adjust for 
screening coverage due to the absence of nationwide 
screening data for women living with HIV. While dis-
parities in ICC incidence by ethnicity have been shown 
in South Africa, we lacked information on ethnicity in 
our data which might have explained some of the differ-
ences in ICC across municipalities [31]. Prior to 2011, 
NCR consisted mainly of cancer cases reported by pub-
lic laboratories. In 2011, compulsory cancer reporting 
was established by both private and public laborato-
ries [15, 55]. This is not expected to have substantially 
affected ICC reporting in HIV-positive women, since 
almost all HIV-positive women receive treatment 
through public sector services. Lastly, in our study, we 
could not assess any of the aforenmentioned different 
metrics pertaining to access. We should also note that 
we assumed that the municipality of the health facil-
ity is the same as the municipality of residence. This 
assumption may be problematic as people can move to 
other provinces and municipalities for healthcare. For 
instance, municipalities with more facilities might have 
better accessibility and shorter waiting times and hence 
people might choose to go there instead. Thus, we can-
not rule out that the observed effect can be driven by 
this assumption.
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Conclusion
In conclusion, although the burden of ICC among 
women diagnosed with HIV has decreased over time, 
there was strong spatial variation. Individuals from 
less deprived areas and areas with more health facili-
ties are more likely to be diagnosed with ICC compared 
to those from most deprived areas or areas with fewer 
health facilities. The geographical discrepancies per-
sisted after adjusting for the aforementioned factors, 
which could reflect spatial differences in screening poli-
cies across women living with HIV. More efforts should 
be made to ensure equitable access to health services, 
including mitigating physical barriers, such as trans-
portation to health centres, strengthening of screen-
ing programmes, and nationwide HPV vaccination 
implementation in populations living with HIV. Special 
attention should be paid to women living in low socio-
economic areas.
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